Management of High-Risk Upper GI Bleeding

Initial Management

For patients with bleeding peptic ulcers and high-risk stigmata after successful endoscopic hemostasis, the American College of Gastroenterology recommends using pantoprazole 80 mg IV bolus followed by 8 mg/hour continuous infusion for 72 hours, rather than 80 mg twice daily 1, 2, 3, 4, 5
The American College of Gastroenterology suggests that the continuous infusion regimen is specifically designed to maintain intragastric pH above 6, which is critical for platelet aggregation and clot stability 1, 2, 3

The American College of Gastroenterology recommends an initial 80 mg IV bolus immediately after endoscopic hemostasis, followed by 8 mg/hour continuous infusion for 72 hours 1, 2, 3, 4, 5
The American Gastroenterological Association suggests switching to oral PPI twice daily (e.g., pantoprazole 40 mg BD or omeprazole 40 mg BD) after completing the 72-hour infusion, as twice-daily dosing reduces rebleeding risk (RR 0.37, 95% CI 0.19-0.73) compared to once-daily dosing in high-risk patients 1, 2, 6
The World Gastroenterology Organisation recommends continuing once-daily oral PPI for 6-8 weeks total to allow complete mucosal healing, and notes that long-term PPI is not recommended unless ongoing NSAID use 3, 5

The International Consensus Guidelines recommend starting PPI therapy as soon as possible, even before endoscopy, and administering pre-endoscopy erythromycin to improve gastric visualization 3, 5
The American College of Gastroenterology suggests performing urgent endoscopy and identifying high-risk stigmata (Forrest Ia, Ib, IIa: active bleeding, visible vessel, adherent clot) 3, 5
The European Society of Gastrointestinal Endoscopy recommends that if high-risk stigmata are present after successful hemostasis, an 80 mg IV bolus should be followed by 8 mg/hr × 72 hours 1, 2, 3, 4, 5

The American College of Gastroenterology warns against discontinuing infusion too early, as the full 72-hour infusion is needed to maintain therapeutic pH levels 1, 2, 3
The American Gastroenterological Association notes that stopping PPI at 72 hours increases rebleeding risk, and recommends transitioning to oral therapy 1, 2, 6
The World Gastroenterology Organisation suggests that failure to eradicate H. pylori leads to 40-50% recurrence rates over 10 years, and recommends testing and treating for H. pylori infection 5